AJTMH Transactions of the Royal Society of Tropical Medicine and Hygiene
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 64(5), 2001, pp. 223-228
Copyright © 2001 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, W.
Right arrow Articles by Hoffman, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, W.
Right arrow Articles by Hoffman, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHLOROQUINE
*DOXYCYCLINE
Medline Plus Health Information
*Malaria
Related Collections
Right arrow Travel Medicine
Right arrow Health Outcomes
Right arrow Malaria
American Journal of Tropical Medicine and Hygiene, Vol 64, Issue 5, 223-228
Copyright © 2001 by American Society of Tropical Medicine and Hygiene

Research Articles


Chloroquine/doxycycline combination versus chloroquine alone, and doxycycline alone for the treatment of Plasmodium falciparum and Plasmodium vivax malaria in northeastern Irian Jaya, Indonesia

WR Taylor, H Widjaja, TL Richie, H Basri, C Ohrt, Tjitra, E Taufik, TR Jones, KC Kain, and SL Hoffman

Combination therapy is one method of overcoming the global challenge of drug-resistant Plasmodium falciparum malaria. We conducted a hospital-based 28-day in vivo test comparing chloroquine/doxycycline to chloroquine or doxycycline alone for treating P. falciparum and Plasmodium vivax malaria in Irian Jaya, Indonesia. Eighty-nine patients with uncomplicated falciparum malaria were randomized to standard dose chloroquine (n = 30), doxycycline (100 mg every 12 hours [7 days], n = 20), or chloroquine with doxycycline (n = 39); corresponding numbers for vivax malaria (n = 63) were 23, 16, 24. Endpoints were parasite sensitivity (S) or resistance (RI/RII/RIII). Of the 105 evaluable patients, chloroquine/doxycycline cured (S) 20/22 (90.9% [95% CI 78.9-100%]) patients with P. falciparum malaria; 2/22 (9.1% [0-21%]) were RIII resistant. Doxycycline cured 11/17 (64.7% [42.0-87.4%]) patients, and chloroquine 4/20 (20% [2.5-37.5%]). Against P. vivax, chloroquine/doxycycline cured (S) 12/17 (70.6% [48.9-92.2%]) patients, doxycycline 4/12 (33.3% [6.6-59.9%]), and chloroquine 5/17 (29.4% [7.7-51.1%]). Chloroquine/doxycycline was effective against P. falciparum but only modestly effective against P. vivax. These findings support the use of chloroquine/doxycycline as an inexpensive alternative to mefloquine for treating chloroquine-resistant P. falciparum but not chloroquine-resistant P. vivax in this setting.


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
E. L. Dahl and P. J. Rosenthal
Multiple Antibiotics Exert Delayed Effects against the Plasmodium falciparum Apicoplast
Antimicrob. Agents Chemother., October 1, 2007; 51(10): 3485 - 3490.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
P. N. Newton, J.-F. Chaulet, A. Brockman, W. Chierakul, A. Dondorp, R. Ruangveerayuth, S. Looareesuwan, C. Mounier, and N. J. White
Pharmacokinetics of Oral Doxycycline during Combination Treatment of Severe Falciparum Malaria
Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1622 - 1625.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J. K. Baird
Chloroquine Resistance in Plasmodium vivax
Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4075 - 4083.
[Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
I. W. SUMAWINATA, BERNADETA, B. LEKSANA, A. SUTAMIHARDJA, PURNOMO, B. SUBIANTO, SEKARTUTI, D. J. FRYAUFF, and J. K. BAIRD
VERY HIGH RISK OF THERAPEUTIC FAILURE WITH CHLOROQUINE FOR UNCOMPLICATED PLASMODIUM FALCIPARUM AND P. VIVAX MALARIA IN INDONESIAN PAPUA
Am J Trop Med Hyg, April 1, 2003; 68(4): 416 - 420.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. D. Hastings and C. H. Sibley
Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax
PNAS, October 1, 2002; 99(20): 13137 - 13141.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
C. Ohrt, G. D. Willingmyre, P. Lee, C. Knirsch, and W. Milhous
Assessment of Azithromycin in Combination with Other Antimalarial Drugs against Plasmodium falciparum In Vitro
Antimicrob. Agents Chemother., August 1, 2002; 46(8): 2518 - 2524.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Tropical Medicine and Hygiene.